companydata.dkAbacus Medicine Pharmaceuticals ApS: Financial statements 2022
CVR: 39192063
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -36,339 and a net result of DKK -4,553,460 compared with DKK 2,778,732 the year before. Equity amounted to DKK 20,797,410. The solvency ratio was 20.1%.
- Gross Profit
- -36,339 kr.
- Profit/Loss
- -4,553,460 kr.
- Equity
- 20,797,410 kr.
- Total Assets
- 103,223,545 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -36 t. | -4.6 mio. | 20.8 mio. | 0 |
| 2021 | - | -43 t. | 2.8 mio. | 25.4 mio. | 0 |
| 2020 | - | -63 t. | 188 t. | 22.6 mio. | 0 |
| 2019 | - | -212 t. | 548 t. | 15.9 mio. | 0 |
| 2018 | - | -62 t. | 860 t. | 15.3 mio. | - |
Keep an eye on Abacus Medicine Pharmaceuticals ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2021. Gross profit came to DKK -43,133, and the net result was DKK 2,778,732.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity amounted to DKK 14,264,000.